S.Biotex Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-11-2024
- Paid Up Capital ₹ 1.00 M
as on 02-11-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.71 Cr
as on 02-11-2024
- Revenue -44.17%
(FY 2023)
- Profit -86.79%
(FY 2023)
- Ebitda -53.55%
(FY 2023)
- Net Worth 7.41%
(FY 2023)
- Total Assets 59.42%
(FY 2023)
About S.Biotex
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.71 Cr.
Ashish Jain, Subhash Chander, and Sugandha Jain serve as directors at the Company.
- CIN/LLPIN
U17299PB2020PTC052045
- Company No.
052045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does S.Biotex Private Limited offer?
S.Biotex Private Limited offers a wide range of products and services, including Face Mask & Medical PPE Kits, Face Mask, Apparel Fabrics & Clothing Textiles, Jersey & Knitted Fabric, Printed Fabrics, Medical & Industrial Mask, Ladies Suits & Dress Material, Jacquard Fabric, Men Shirts, Jeans & Clothing, Men T-Shirts.
Who are the key members and board of directors at S.Biotex?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashish Jain | Director | 10-Oct-2020 | Current |
Subhash Chander | Director | 10-Oct-2020 | Current |
Sugandha Jain | Director | 10-Oct-2020 | Current |
Financial Performance of S.Biotex.
S.Biotex Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.17% decrease. The company also saw a substantial fall in profitability, with a 86.79% decrease in profit. The company's net worth moved up by a moderate rise of 7.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of S.Biotex?
Unlock access to S.Biotex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Swami Textiles Private LimitedActive 28 years 6 months
Ashish Jain and Subhash Chander are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 20 Mar 2021 | ₹8.71 Cr | Open |
How Many Employees Work at S.Biotex?
S.Biotex has a workforce of 17 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S.Biotex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.Biotex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.